Daniel Adamson is a Senior Managing Director and serves on Wafra’s Management Advisory Committee. Mr. Adamson leads Wafra’s efforts in business and product development, building financial and strategic solutions for sovereign investors and pension funds. He is also the President of Capital Constellation, a joint venture between asset owners in Europe, North America and the Middle East, investing in the next generation of alternatives managers.

Previously, Mr. Adamson held senior positions at Ares Management and Bridgewater Associates. He began his career at McKinsey & Company.

Mr. Adamson earned a BA, summa cum laude, from Yale University, an MPhil in Politics from Oxford University, where he was a Marshall Scholar and a JD from the Yale Law School. He currently serves on the External Advisory Board for Strategic Investment Funds at the World Bank.

Vivianne Akriche is Managing Director of Eurazeo Capital, based in New York. She is responsible for sourcing and executing investments and overseeing the performance of Eurazeo’s portfolio companies. Vivianne specializes in the consumer and business services sectors and has notably participated in the structuring and/or oversight of the investments in Rexel, Intercos, Moncler, Fonroche, Les Petits Chaperons Rouges, Sommet Education and Worldstrides. She was also involved in the strategic acquisition of OFI PE, which subsequently became Eurazeo PME. She currently serves on the boards of Grandir SA (holding of Les Petits Chaperons Rouges), Graduate (holding company for Sommet Education) and Lakeland LLC (holding company for WorldStrides).

Before joining Eurazeo in 2004, Vivianne was part of the investment banking team at Goldman Sachs in Paris.

Vivianne holds master’s degree from H.E.C. School of Management in Paris.

In December 2018, The Financial Times described Frank Aquila as “one of the most influential and high-profile M&A and corporate lawyers in the U.S.” who has “played a role in many of the largest and most complex deals.” In December 2019, Mr. Aquila was one of the dealmakers profiled in an article in The Financial Times titled “Deal lawyers are masters of seeing the next move.” The Wall Street Journal profiled him as one of the six top dealmakers of the year in 2019 and one of the seven top dealmakers in 2018. These recognitions highlight Mr. Aquila’s consistently broad multidisciplinary practice.

During the course of his career, Mr. Aquila has advised on deals totaling more than $1 trillion in value, including advising on more than $100 billion in 2019. He has been called upon by global leaders such as Amgen, Andeavor, Anheuser-Busch InBev, Cheniere Energy, Diageo, Diebold Nixdorf, International Airline Group, Kraft, Navistar International, Novartis, Tiffany & Co. and United Rentals to advise them and their boards of directors on M&A, proxy contests, activism, unsolicited bids, corporate governance, crisis management and a range of matters affecting corporate policy and strategy.

Mr. Aquila is a member of the Firm’s Management Committee and is Global Head of the Firm’s M&A Practice. Previously, Mr. Aquila was the co-managing partner of Sullivan & Cromwell’s General Practice Group (the Firm’s global corporate practice) and in that role he was responsible for almost 500 lawyers in 12 offices around the world.

Jeff is a Managing Director and the Global Head of Direct Equity Investments where he is responsible for direction and oversight of the firm’s Co-Investment platform. Jeff has over 20 years of private equity and public market investing experience and has served on the board of directors of several portfolio companies and non-profit organizations.

Prior to joining Hamilton Lane in 2018, Jeff was a Managing Director at Versa Capital Management, where he focused on making control-oriented, special situations, debt and equity investments in middle market companies across a variety of industries. While at Versa, Jeff participated in all major investment functions and his responsibilities included origination, underwriting, transaction execution and portfolio company development. Prior to joining Versa in 2003, Jeff was an Equity Research analyst at Oppenheimer + Close. He has also held private equity, venture capital, corporate development and investment banking positions at Berwind Financial Group, Redleaf Group, ICG Commerce and Wheat First Butcher Singer, respectively.

Christian Alejandro Asmar is co-founder and Managing Partner of Impactive Capital.

Prior to founding Impactive, Christian spent 8 years at Blue Harbour Group, a $3 billion activist investment firm where he was a Managing Director and Investing Partner. Christian led many firms investments where he advised CEOs and boards of public companies on capital allocation, ESG issues, and strategic considerations. Prior to joining Blue Harbour Christian was a founding team member of Morgan Stanley Infrastructure Partners (MSIP), a $4 billion infrastructure fund, where he worked in infrastructure investments in the energy, transportation and social infrastructure sectors and served on the board of multi-billion dollar private infrastructure assets. Prior to his tenure at MSIP, Christian worked in the Investment Banking division at Morgan Stanley where he structured and executed project level financings in emerging markets and Latin America.

Andrew Bab is a corporate partner, member of the firm’s Mergers & Acquisitions and Private Equity Groups, and Co-Head of the Healthcare & Life Sciences Group. Mr. Bab has worked extensively on public and private acquisitions, divestitures and joint ventures, including cross-border transactions for both private equity and corporate clients, as well as licensing arrangements and other corporate transactions. He has experience across many industries, but is particularly active in the healthcare sector. In addition, he frequently advises Deutsche Bank, Guggenheim Securities, J.P. Morgan Securities, Morgan Stanley and other investment banks on major M&A transactions. Mr. Bab led The Deal’s “Private Equity Deal of the Year” for representing TPG Capital and Welsh, Carson, Anderson & Stowe, together with Humana, in their $4.1 billion acquisition of Kindred Healthcare.

Ge Bai, PhD, CPA is an associate professor of Accounting at Johns Hopkins Carey Business School and associate professor of Health Policy & Management (joint) at Johns Hopkins Bloomberg School of Public Health. She is an expert on health care pricing, policy, and management. Dr. Bai has testified before House Ways and Means Committee, written for the Wall Street Journal, and published her studies in leading academic journals such as the New England Journal of Medicine, JAMA, JAMA Internal Medicine, Annals of Internal Medicine, and Health Affairs. Her work has been widely featured in ABC, CBS, CNN, Fox News, Los Angeles Times, NBC, New York Times, NPR, the Wall Street Journal, Washington Post, and other media and used in government regulations and congressional testimonies.

Lara Banks, a Managing Director, is co-head of Makena’s Private Equity team, responsible for day-to-day portfolio management and manager selection across private equity investments. Lara is also a member of Makena’s Management and Investment Committees. In addition to her duties overseeing private equity investments, Lara leads the firm’s sustainability efforts as they relate to investment diligence and oversight. Prior to joining Makena in 2012, Lara was an associate at GE Energy Financial Services, a financial division investing across the capital structure of energy assets. At GE, Lara analyzed investments in domestic and foreign oil and gas fields. Prior to GE, Lara was a power markets analyst at DC Energy, a proprietary energy trading firm. Lara earned an M.B.A. from Harvard Business School and a B.A. in Economics and Government, magna cum laude, from Cornell University.

Nathan Bays is an experienced healthcare executive with experience in investment banking, health policy venture capital, and law, advising Leading Health Systems, early and growth stage companies, and financial sponsors on M&A, strategy, and health policy. He is a senior banker at Citigroup, focused on M&A and strategic advisory with Leading Health Systems and health services companies.

Prior to joining Citi, Mr. Bays was a senior M&A advisor at Cain Brothers, advising health systems, physician groups, and health information technology and services companies on transactions, partnerships, and affiliations.

Nathan is a frequent author and speaker on industry trends, strategy, the M&A landscape, and health policy. He is a member of the Board of Directors of UniteUs, the Health Policy Council at The Health Management Academy, and a Venture Partner at LifeForce Capital.

Nathan received his juris doctor from Wake Forest University School of Law.

Mike Blankenship focuses his practice on corporate finance, M&A, private equity and securities law. He regularly counsels public companies on strategic transactions, capital markets offerings, and general corporate and securities law matters. Mike represents both issuers and underwriters in U.S. and international capital markets transactions, including initial public offerings, and advises on corporate governance and securities market regulation.

Brian is the Head of Corporate Strategy and M&A for Church & Dwight based out of Ewing, NJ – Church & Dwight is a manufacturer of consumer and specialty products and owns such iconic brands as Arm & Hammer, Trojan, OxiClean, Waterpik, First Response, Vitafusion, Flawless, Spinbrush, Nair and Orajel with total sales of $4.5 billion and an enterprise value of over $20 billion.  Since joining Church & Dwight in 2006 the company has acquired 16 brands with an aggregate transaction value over $4.3 billion including:  Flawless hair removal devices, Waterpik water flossers, Passport Food Safety, Agro Biosciences Animal Nutrition, Viviscal hair care, Anusol hemorrhoid business, Toppik hair fiber care, Vi-Cor Animal Nutrition, RepHresh and Replens Women’s health brands, Avid Health (L’il Critters and VitaFusion gummy vitamins), OxiClean, Orajel, Simply Saline, Batiste, Toothtunes and Feline Pine brands and sold nine brands as well.  Brian also is on the board of directors of the Armand Products JV in the Specialty Products Division for Church & Dwight.

Ray A. Cameron, Managing Director, is the Head of BlackRock’s Investment Stewardship team for the Americas region based in New York. In this role, Ray leads a team of specialists responsible for engagement and proxy voting activities in relation to the companies in which BlackRock invests on behalf of clients. Through direct engagement with companies, the team encourages corporate governance practices that support sustainable financial performance over the long-term.

Prior to joining BlackRock, Ray most recently managed the corporate access engagement practice at several investment banking firms, including Stifel and Cowen. In these capacities, he oversaw teams that established and enhanced constructive dialogue with hundreds of portfolio companies’ boards and management teams.

Ray earned his Masters of Business Administration degree from Southern Methodist University, Dallas, Texas and his Bachelors of Business Administration degree from The University of Texas at Austin.

Benjamin Colton is a Global Co-Head of Asset Stewardship within State Street Global Advisors (SSGA).  He and his team are responsible for developing and implementing SSGA’s global proxy voting policies and guidelines across all investment strategies, and managing SSGA’s proxy voting activities and issuer engagement on ESG issues.

Prior to his current role, he was based out of Tokyo, Japan serving as the Head of Asia-Pacific leading SSGA’s Asset Stewardship efforts across the region.

Prior to joining SSGA in 2018, he worked at Norges Bank Investment Management for a total of eight years based in Oslo, Norway and later in New York City.

He earned Master’s degrees from both the London School of Economics & Political Science and the University of Nevada, Reno.

Bill Detwiler is a founding partner of Fernbrook Capital Management LLC, manager of the Fernbrook Convergence Fund. Fernbrook invests globally in the digital commerce industry, including digitally-native brands, marketplaces, B2B e-commerce solutions, payment service providers, and merchant services. Fernbrook pairs operating and finance expertise with a deep relationship network to help companies scale. Fernbrook is an inclusive, female-led venture firm, 75% female and 25% persons of color, with a diverse group of portfolio founders and management teams. 60% of founders are Women and over 25% are BIPOC founders.

Bill is based in New York and served on the boards of portfolio companies and non-profit organizations.

Andrew Dunn joined OEP in 2008 and is a Managing Director based in New York. During his tenure at OEP, Mr. Dunn has worked on a range of investments in the business services, technology, media and telecommunications industries. Mr. Dunn is currently a member of the Board of Directors of Allegro Microsystems, MediaKind, Neology and Zodiac Systems. Mr. Dunn was previously involved in OEP’s investments in Genband, Mandiant, Netas, Travelport and TV Guide.

Prior to joining OEP, Mr. Dunn worked at the Boston Consulting Group, where he primarily served clients in the media and telecommunications sectors. Mr. Dunn received his M.P.P. focused on International Trade and Finance from the Harvard Kennedy School and his B.A. (double first class honors) in Modern History from the University of Oxford.

Victoria Emerick has a PhD in Biochemistry and certifications in Project & Change Management as well as Lean & Six Sigma. Over the last 25 years, she’s focused on strategic operations, continuous improvement, & enterprise level project planning & management. In her current role as the Global Head of Sustainability Strategy and Operations, Victoria is responsible for developing innovative approaches to advance Sustainability-ESG efforts across the entire Bristol-Myers Squibb network.

Mr. Evans is a Managing Director and Head of Healthcare Finance of Monroe Capital. He is responsible for relationship sourcing and the origination of new business opportunities within the healthcare industry. Mr. Evans has over 19 years of experience in healthcare finance. Prior to Monroe, he was at Principal at Beverly Capital, a healthcare focused private equity firm. He was formerly a Vice President in the Healthcare Leveraged Finance group at Madison Capital where he originated, structured and underwrote debt financing for private equity sponsored transactions. Prior to Madison Capital, Mr. Evans worked in Merrill Lynch Capital Healthcare Finance’s leveraged lending group. He earned his M.B.A. from the Northwestern University’s Kellogg School of Management and his B.A. in Economics from the University of Michigan.

Alexis J. Gilman is a partner in Crowell & Moring’s Antitrust Group in Washington, D.C. Alexis advises and represents clients on a broad range of civil antitrust matters, including merger reviews and clearances, government investigations, premerger Hart-Scott-Rodino (HSR) notifications, and antitrust litigation, with a particular focus on representing merging parties and third parties in merger investigations by the Federal Trade Commission, Department of Justice, and state attorneys general offices. His experience spans a wide range of industries, with a particular emphasis on healthcare mergers and acquisitions. Alexis was recognized by Who’s Who Legal in the category Competition Future Leaders – Partners in 2019 and 2020, as a Recommended Lawyer by Legal 500 in the category Antitrust: Merger Control in 2020, and by Best Lawyers in America 2021 for Antitrust.

Ms. Jelena Guzenko is Vice President of Mergers & Acquisitions, heading M&A for Siemens Energy, Americas, based out of New York City. Prior to that, since 2011, she was a Director of Mergers and Acquisitions for Siemens Corporation’s Manhattan-based office, responsible for leading M&A transactions on both buy and sell sides for all divisions of Siemens for the Americas region while leading negotiations and large cross-functional teams of experts through all stages of the M&A processes. Ms. Guzenko also has particular expertise in directing large multi-country corporate carve-outs. She has significant experience in development of global strategies for multi-billion dollar divisions, as well as business and market analytics and forecasting in various industries, including Energy, Healthcare, Telecommunications, Construction and Manufacturing. Ms. Guzenko holds an M.B.A. (“Dipl.-KFF. (FH)”) from University of Applied Sciences Cologne, in Germany, and is fluent in four languages.

Matthew Heinz is a senior managing director and co-practice leader of Aon’s Transaction Solutions team. Matt heads the representations and warranties insurance business. He previously worked as a broker in Aon’s Private Equity and Transaction Solutions group, which served as a national resource in the private equity space for the broader Financial Services group. Matt began his insurance brokerage career at Aon in 2010. Prior to joining Aon, Matt underwrote R&W, Tax and Contingent Liability insurance at AIG and managed their Mergers and Acquisitions Insurance group. Matt began his professional career as a corporate attorney with Proskauer Rose LLP in New York City, where he mainly practiced M&A before entering the insurance field.

Michael K. Hyun was named deputy general counsel and corporate secretary effective January 2017. He is the corporate secretary of Public Service Enterprise Group Incorporated (PSEG) and its subsidiaries, including Public Service Electric and Gas Company (PSE&G) and PSEG Power, and is responsible for corporate governance and the administration of the Board of Directors meeting agendas and processes. In addition, as deputy general counsel, he is responsible for corporate, securities and transactional matters across PSEG including disclosures, capital markets transactions and mergers and acquisitions. Mr. Hyun also oversees PSEG’s shareholder services.

Prior to joining PSEG, Mr. Hyun was a corporate associate at Cravath, Swaine & Moore LLP.

Mr. Hyun graduated from Columbia Law School with a Doctor of Law (J.D.) and has a Bachelor of Laws (LL.B) from Seoul National University.

Lonne Jaffe is a managing director at Insight Partners, and joined the firm in 2017. He was previously the CEO of Insight portfolio company Syncsort, which he joined in 2013 after serving as the senior vice president for corporate strategy at CA Technologies. Prior to CA, Lonne spent over a decade at IBM, where he led a number of sizable software acquisitions and held various technology strategy and operating executive roles.

Lonne received undergraduate (Walt Disney Company Foundation Scholarship, Detur Book Prize, Phi Beta Kappa) and master’s degrees from Harvard University.

Eric Johnson is Co-Chair of Winston & Strawn’s ESG Advisory Team. A Partner in Winston’s Houston office, Eric has focused his practice for over 20 years on energy mergers and acquisitions, capital markets transactions and public company governance matters, including ESG and energy transition issues. Winston & Strawn, LLP is a global law firm founded in 1853 with more than 950 attorneys serving as trusted advisors to clients in every industry around the world.

Rakhi Kumar is Senior Vice President at Liberty Mutual, where she leads efforts to integrate sustainability across the global enterprise. She is responsible for developing environmental, social and governance (ESG) integration strategies for the different business lines in close collaboration with business leaders and for advising the businesses in its implementation.

Rakhi is a globally recognized leader in the area of sustainability and was recognized as such by the National Association of Corporate Directors (NACD). She has also been identified as Boston’s 100 Most Influential People of Color by the Greater Boston Chamber of Commerce, The Boston Foundation and Get Konnected!, and is a recipient of the Abigail Adams Award for her work in promoting gender diversity on corporate boards.

She is an Advisory Board Member on the Millstein Center for Global Markets and Corporate Ownership at the Columbia Law School and has earned her MBA (’02) from Yale University and her Bachelors of Commerce (’95) from Bombay University.

In October 2010, Erik joined as head of corporate development and strategy for DMGT’s B2B information subsidiary, DMG Information. In March 2017, he was promoted to DMGT, Group Head Corporate Development and M&A, with responsibilities across DMGT’s global portfolio of businesses. In his role, Erik leads the evaluation and execution of inorganic growth opportunities, including acquisitions. Prior to DMGT, he held several corporate development and strategy positions at companies, including LexisNexis, PRIMEDIA and Marakon Associates. Erik graduated with honors from Vassar College and obtained his MBA from the Wharton School of the University of Pennsylvania. He resides in Manhattan.

Todd Manning is Vice President, Corporate Development / M&A, at American Express. Since joining American Express in 2009, he has evaluated hundreds of acquisitions, divestitures and investment opportunities on behalf of every major business unit in the company globally. His transactions include the acquisitions of Kabbage, Mezi and inAuth, divestitures of merchant acquiring businesses in the Czech Republic and Panama as well as investments in BigCommerce and iZettle.

Todd graduated from the UCLA Anderson School of Management where he obtained his MBA with a concentration in Finance. He is originally from New Hampshire, but currently resides in Connecticut with his wife and two children.

Gregg focuses on investments in Healthcare IT and Enterprise software, specifically marketing technology. He also advises Edison portfolio executives on strategy, operational efficiency, and leadership. He brings 20 years of experience leading HCIT and media organizations, and a consistent track record of developing and executing innovative business strategies that deliver bottom line results.

Gregg currently serves as a Director for Health Recovery Solutions, PurpleLab, Gambling.com, PathFactory, Wyng, and Lincor Solutions.

Kevin L. Miller is a transactional attorney who primarily represents private equity sponsors and their portfolio companies with respect to the corporate, securities, tax and regulatory aspects of complex transactions (including leveraged buyouts) in the health services and life sciences industries. Kevin also represents physician groups, publicly traded health care companies, academic medical centers and nonprofit health systems with respect to corporate and transactional matters.

Kevin is a leader in the firm’s health care private equity and physician practice management initiatives. Within the practice management space, Kevin has extensive
experience with both multi-specialty and single-specialty platforms providing services in both the acute care and outpatient/office-based delivery environments. He also regularly advises on dental practice management, acute care facility, behavioral health and substance abuse, urgent care, physical, occupational and speech therapy, hospice and home health, laboratory services, pharmacy, telemedicine and medical device businesses.

Elizabeth Mily is Executive Vice President, Strategy & Business Development, at Bristol Myers Squibb. In this role, she oversees the company strategy and all business development activities, including strategic partnerships, mergers and acquisitions, as well as other strategic initiatives. Elizabeth is instrumental in the company’s approach to source scientific innovations across commercial, development, discovery and technology platforms to complement the company’s internal R&D pipeline. Elizabeth was appointed to the position in March 2020.

Elizabeth holds a Master of Science in Foreign Service from Georgetown University and a Bachelor of Arts in German Literature and European History from The Ohio State University. She was also a Fulbright Scholar to the Universities of Cologne and Hamburg, Germany. Elizabeth also completed a Congress-Bundestag scholarship in Bonn, Germany.

Thomas M. Moriarty is an accomplished business strategy, legal and policy executive who has held leadership positions at some of the largest and most innovative health care companies in the country. In his current role at CVS Health, a Fortune 5 company with the mission of helping people on their path to better health, he is responsible for the brand and reputation strategy for the company in leading the external affairs function, which includes the corporate communications, policy and government affairs teams, as well as leading the legal and regulatory departments.

Mr. Moriarty has established himself as a trusted advisor within the company and is committed to evolving CVS Health’s role in the health care industry to make health care more accessible and affordable, and to deliver better outcomes for patients in the process.

Paul Parker was named Senior Vice President of Strategy and Corporate Development at Thermo Fisher Scientific in April 2020, with responsibility for corporate strategy, mergers and acquisitions, and other corporate development opportunities.

Paul has more than 30 years of M&A banking experience in multiple sectors and geographies. Prior to joining Thermo Fisher, Paul served as Co-Chairman of the Global Mergers and Acquisitions Group in the Investment Banking Division for Goldman Sachs & Co. He also served on the firm’s Partnership Committee and on the Investment Banking Senior Leadership Council. Prior to Goldman Sachs, Paul worked as Chairman and Head of Global M&A at both Barclays and Lehman Brothers. He served on the Executive Committee for the Investment Banking Division of both companies and on the Americas Management Committee for Barclays Group.

Paul earned an MBA with distinction from Harvard Business School and a bachelor’s degree in international studies from the University of North Carolina at Chapel Hill.

Vip Patel is a senior broker in Aon’s Transaction Solutions Practice and focuses on the placement, brokering, structuring and negotiation of representations and warranties insurance policies in connection with mergers and acquisitions by private equity firms and corporations.

Prior to joining Aon’s Transaction Solutions team in January 2015, Vip most recently was a vice president in the healthcare investment banking group at Robert W. Baird, where he focused on mergers, acquisitions and capital raising transactions. Prior to that, Vip was an associate in the healthcare investment banking group at Deutsche Bank focusing on mergers, acquisitions and financing transactions. Before his career in investment banking, Vip was a corporate attorney with O’Melveny & Myers and Jones Day focusing on mergers, acquisitions, leveraged buyouts and securities offerings.

Arielle Patrick is Executive Vice President & Transaction Director in the Financial Communications & Capital Markets group at Edelman, based in New York. Arielle helps lead the firm’s offering for mergers & acquisitions, bankruptcy/restructuring, and other transactions. She is an advisor to CEOs and boards of directors of public and private companies, providing counsel on communications strategies for all stakeholder audiences (e.g. investor, regulator, employee, vendor, supplier, customer, partner, media, etc.) to protect and build corporate reputation.

Prior to joining Edelman, Arielle was a leader of the financial communications team within the Corporate Crisis & Issues Management practice at global PR firm, Weber Shandwick (a subsidiary of Interpublic Group). She earned an undergraduate degree in Classics (Ancient Greek and Latin) from Princeton University.

Larry Perkins is the CEO & Founder of SierraConstellation Partners and has nearly 20 years of management consulting and advisory experience with companies undergoing transition. Larry has enhanced business performance for numerous companies on projects ranging from interim management, profit improvement and working capital management to strategic planning and transaction execution.

Larry began his career in the strategic consulting group of Arthur Andersen after graduating from the University of Southern California Marshall School of Business. He was born and raised in Southern California and attended Polytechnic School in Pasadena where he served on the school’s board of directors. He is also on the board of Heart of Los Angeles, and two corporate boards based in Los Angeles. Larry is a member of the Young Presidents Organization.

Justin Rawlins is a partner in the Finance and Restructuring practice, based in the firm’s Los Angeles office. He has extensive experience representing clients in various bankruptcy matters and is consistently ranked as a leading bankruptcy lawyer in top legal directories. Mr. Rawlins principally represents funds, lending institutions, companies, and committees in providing a broad spectrum of services, including counseling on corporate governance matters, fund formation, acquisitions, divestitures, debt offerings, refinancings, and recapitalizations, with an emphasis on distressed and special situations.

Jeff Rhodes is a Partner of TPG in the San Francisco office, where he co-leads the healthcare group and the firm’s investment activities in the healthcare services, pharmaceutical, and medical device sectors. Jeff serves on the boards of BVI, Immucor, Kelsey Seybold Clinic, Kindred at Home, Kindred Healthcare, Lifestance and WellSky. He previously served on the Boards of Biomet, EnvisionRx, IMS Health, Par Pharmaceutical Companies, Surgical Care Affiliates, Zimmer Biomet and as a founding Board member of the Healthcare Private Equity Association. He also serves on the Leadership Council of The Nature Conservancy California, the Governing Council of The Wilderness Society, and is Vice Chairman of the Northstar Teams Foundation (Ski and Snowboard). Jeff received his MBA from the Harvard Business School and earned his BA from Williams College.

Ms. Rice is a managing director in Oaktree’s Special Situations Group and leads the group’s investing efforts in the healthcare and retail sectors. She also plays an active role in execution of complex restructuring and recapitalization transactions outside of her primary industry coverage. Prior to joining Oaktree in 2009, Ms. Rice spent two years as an associate at Lindsay Goldberg, LLC, and before that, she spent two years as an analyst in the Leveraged Finance group at Deutsche Bank. Ms. Rice currently serves on the Board of Directors for Floatel International. She holds an A.B. degree in biology magna cum laude with highest honors from Harvard College and an M.B.A. from Wharton School at the University of Pennsylvania, where she was a Palmer Scholar.

For 22 years, Alex has advised companies, creditors and other stakeholders in varied distressed and special situations involving approximately $80 billion of financial obligations. He has comprehensive experience in special situations driven by overall economic conditions, capital market trends, sector disruptions or situation-specific factors such as poor management, customer loss and commodity prices. He drives consensual resolution of these complex issues for his clients. In addition, Alex leverages extensive lender relationships to deliver strategic, bespoke financing alternatives for clients requiring structured or specialized financing solutions.

Alex has been instrumental in establishing and building Lincoln’s relationships in the restructuring market both nationally and locally, and successfully raised both debt and equity capital to complete restructuring and other transactions. He has advised on distressed M&A, amendments, waivers, debt for equity conversions, plans of reorganization and other financial restructuring transactions and has extensive experience executing transactions through the Chapter 11 process.

Chris Sugden is Managing Partner of Edison Partners and Chairman of the firm’s investment committee. He is the leading financial technology investor on the East Coast, investing in the industry for more than 16 years.

Chris is a successful entrepreneur, experienced in finance, business strategy, product management, sales, marketing and capital formation. He has deep domain, investment expertise and successful exits in payments, capital markets and wealth management segments.

He has led over 30 financings, including 20+ new investments, and has served as a Director of more than 20 companies.

Previously, Chris was an Executive Vice President with Princeton eCom; CEO of the electronic billing division. Earlier, holding the role of CFO, he raised multiple rounds of venture capital and completed an acquisition.

Robbert Vorhoff is a Managing Director and Global Head of General Atlantic’s Healthcare sector. He also serves on the firm’s Management Committee. Robb joined GA in 2003 and is based in the firm’s New York Office. He currently serves as a member of the board of directors for Alignment Healthcare, Alternate Solutions Health Network, Doctor on Demand, Landmark Health, Marathon Health, Oak Street Health and OneOncology. Previous portfolio responsibilities have included A Place for Mom, eviCore Healthcare, MedExpress Urgent Care, Align Networks, Grupo Qualicorp, RiskMetrics Group, and NYSE Euronext.

Robb received a B.S. in commerce with a concentration in finance from the McIntire School of Commerce at the University of Virginia. While at UVA, he was awarded the William M. Shermet Scholarship by the McIntire faculty on the basis of academic performance, character, and leadership.

Bryan is currently working in Hong Kong as the Deputy General Counsel at Budweiser Brewing Company APAC Ltd., the publicly traded Asia-Pacific subsidiary of Anheuser-Busch InBev, the world’s leading brewer. Budweiser Brewing Company APAC Limited is the largest beer company in Asia Pacific, and the leader in the premium and super premium beer segments. At Bud APAC, Bryan is the head corporate lawyer responsible for corporate governance, securities, mergers and acquisitions and strategic partnerships. Prior to this role, Bryan worked in New York as the head M&A, treasury and securities lawyer for AB InBev, leading on the disposal of AB InBev’s prior Australian business and the initial public offering of Bud APAC on the Hong Kong Stock Exchange. Prior to joining AB InBev, Bryan was associated with Cleary Gottlieb Steen & Hamilton LLP in New York where he advised private equity firms and multi-national corporations on all aspects of M&A, corporate finance and corporate governance matters. Bryan attended the University of Pennsylvania and NYU School of law.

Rick Zall is chair of Proskauer’s Health Care Industry Practice. Rick advises health care companies, investors and lenders in their most challenging transactions, including private equity investments, mergers and acquisitions, joint ventures, financings and complex commercial agreements.

With a deep understanding of the health care industry, Rick assists clients identify and assess regulatory risks, and conduct comprehensive diligence of target companies. He is known for providing clients practical, creative solutions in order to successfully structure, negotiate and close deals for his clients.

Rick also advises operating company clients on state and federal health care regulatory compliance matters, including the corporate practice of medicine, structuring physician incentive arrangements, digital health, telemedicine, HIPAA, fraud and abuse, Medicare and Medicaid payment reimbursement and value based payment.

Roumi joined the New York office of LMP as a Vice President in August 2017. Most recently, Roumi served as Director in the Financial Institutions Group at UBS Securities, providing strategic advice and transaction support to clients in the financial services sector. Prior to UBS, she was an Associate at Oak Hill Capital Partners and an Analyst in the Financial Institutions Group of Morgan Stanley.

Roumi earned her Bachelor of Arts with High Honors in Mathematical Economics from Colgate University.